Published in J Psychosom Res on August 02, 2007
Surgical sterilization, regret, and race: contemporary patterns. Soc Sci Res (2014) 0.77
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril (2008) 5.31
Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab (2006) 4.56
Polycystic ovary syndrome. Lancet (2007) 3.62
Histological dating of timed endometrial biopsy tissue is not related to fertility status. Fertil Steril (2004) 3.03
Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril (2011) 2.80
Absence of secretory endometrium after false-positive home urine luteinizing hormone testing. Fertil Steril (2004) 2.59
Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab (2005) 2.50
Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 2.28
Predictors of pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2009) 1.90
Diminished paternity and gonadal function with increasing obesity in men. Fertil Steril (2008) 1.90
Family-based analysis of candidate genes for polycystic ovary syndrome. J Clin Endocrinol Metab (2010) 1.84
Letrozole, Gonadotropin, or Clomiphene for Unexplained Infertility. N Engl J Med (2015) 1.65
Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab (2008) 1.65
The effects of a whole grain-enriched hypocaloric diet on cardiovascular disease risk factors in men and women with metabolic syndrome. Am J Clin Nutr (2008) 1.63
Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab (2002) 1.63
Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol (2003) 1.63
Endometrial shedding effect on conception and live birth in women with polycystic ovary syndrome. Obstet Gynecol (2012) 1.62
Sexual function among women with urinary incontinence and pelvic organ prolapse. Am J Obstet Gynecol (2004) 1.53
Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts. J Med Genet (2011) 1.51
Continuous glucose monitoring during pregnancy in women with polycystic ovary syndrome. Obstet Gynecol (2011) 1.42
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome. Proc Natl Acad Sci U S A (2006) 1.38
Catechol-O-methyltransferase (COMT) single nucleotide polymorphisms and haplotypes are not major risk factors for polycystic ovary syndrome. Mol Cell Endocrinol (2011) 1.38
Identification of a polycystic ovary syndrome susceptibility variant in fibrillin-3 and association with a metabolic phenotype. J Clin Endocrinol Metab (2007) 1.37
"What my doctor didn't tell me": examining health care provider advice to overweight and obese pregnant women on gestational weight gain and physical activity. Womens Health Issues (2012) 1.31
Femoral bone structural geometry adapts to mechanical loading and is influenced by sex steroids: the Penn State Young Women's Health Study. Bone (2004) 1.29
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype. Proc Natl Acad Sci U S A (2014) 1.28
Quo vadis randomized controlled trials in infertility? Fertil Steril (2012) 1.23
Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism (2008) 1.20
Evidence for chromosome 2p16.3 polycystic ovary syndrome susceptibility locus in affected women of European ancestry. J Clin Endocrinol Metab (2012) 1.19
Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Mol Endocrinol (2004) 1.18
Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 1.17
Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2. J Clin Endocrinol Metab (2009) 1.17
FTO and MC4R gene variants are associated with obesity in polycystic ovary syndrome. PLoS One (2011) 1.16
Decision trees for identifying predictors of treatment effectiveness in clinical trials and its application to ovulation in a study of women with polycystic ovary syndrome. Hum Reprod (2010) 1.13
The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil Steril (2010) 1.09
A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome. Fertil Steril (2004) 1.07
Effects of race and family history of type 2 diabetes on metabolic status of women with polycystic ovary syndrome. J Clin Endocrinol Metab (2004) 1.06
The role of genes and environment in the etiology of PCOS. Endocrine (2006) 1.05
Recruitment challenges of a multicenter randomized controlled varicocelectomy trial. Fertil Steril (2011) 1.05
Plasma interleukin 6 levels are elevated in polycystic ovary syndrome independently of obesity or sleep apnea. Metabolism (2006) 1.04
Estimating live birth rates after ovulation induction in polycystic ovary syndrome: sample size calculations for the pregnancy in polycystic ovary syndrome trial. Contemp Clin Trials (2005) 1.02
Estimating rates of multiple gestation pregnancies: sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial. Contemp Clin Trials (2011) 1.01
Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet. Hum Reprod (2003) 0.98
Valproate potentiates androgen biosynthesis in human ovarian theca cells. Endocrinology (2003) 0.98
Variation in resistin gene promoter not associated with polycystic ovary syndrome. Diabetes (2003) 0.97
Obesity and the role of gut and adipose hormones in female reproduction. Hum Reprod Update (2006) 0.96
High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity. J Clin Endocrinol Metab (2009) 0.95
The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab (2011) 0.95
Retinoids and retinol differentially regulate steroid biosynthesis in ovarian theca cells isolated from normal cycling women and women with polycystic ovary syndrome. J Clin Endocrinol Metab (2005) 0.95
Perioperative complications of surgery for genital prolapse: does concomitant anti-incontinence surgery increase complications? Urology (2005) 0.93
Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care (2008) 0.93
Prenatal care associated with reduction of neonatal mortality in Sub-Saharan Africa: evidence from Demographic and Health Surveys. Acta Obstet Gynecol Scand (2011) 0.92
The role of TGF-β in polycystic ovary syndrome. Reprod Sci (2013) 0.92
Further investigation in europeans of susceptibility variants for polycystic ovary syndrome discovered in genome-wide association studies of Chinese individuals. J Clin Endocrinol Metab (2015) 0.92
Incomplete and inconsistent reporting of maternal and fetal outcomes in infertility treatment trials. Fertil Steril (2011) 0.91
PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clin Endocrinol (Oxf) (2011) 0.91
Comparison of hormonal and metabolic markers after a high-fat, Western meal versus a low-fat, high-fiber meal in women with polycystic ovary syndrome. Fertil Steril (2008) 0.91
High throughput, cell type-specific analysis of key proteins in human endometrial biopsies of women from fertile and infertile couples. Hum Reprod (2012) 0.91
Oral contraceptive use by teenage women does not affect body composition. Obstet Gynecol (2002) 0.91
Determination of vitamin D in relation to body mass index and race in a defined population of black and white women. Int J Gynaecol Obstet (2012) 0.91
Ovulation induction in women with polycystic ovary syndrome. Steroids (2013) 0.90
Parity and route of delivery: does cesarean delivery reduce bladder symptoms later in life? Am J Obstet Gynecol (2004) 0.89
Association of obesity with treatment outcomes in ovulatory infertile women undergoing superovulation and intrauterine insemination. Fertil Steril (2006) 0.89
Association of prenatal physical activity and gestational weight gain: results from the first baby study. Womens Health Issues (2013) 0.88
Quality of life and sexual function after hysterectomy in women with preoperative pain and depression. Obstet Gynecol (2004) 0.88
Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. Fertil Steril (2010) 0.87
Hyperandrogenic oligomenorrhea and metabolic risks across menopausal transition. J Clin Endocrinol Metab (2014) 0.87
Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome. Fertil Steril (2011) 0.86
Increased transcription and increased messenger ribonucleic acid (mRNA) stability contribute to increased GATA6 mRNA abundance in polycystic ovary syndrome theca cells. J Clin Endocrinol Metab (2005) 0.86
Relative contributions of oligomenorrhea and hyperandrogenemia to the risk of metabolic syndrome in midlife women. J Clin Endocrinol Metab (2012) 0.86
Racial influence on the polycystic ovary syndrome phenotype: a black and white case-control study. Fertil Steril (2011) 0.86
Fear of cancer among women undergoing hysterectomy for benign conditions. Psychosom Med (2005) 0.86
A comparison of methods and results in recruiting white and black women into reproductive studies: the MMC-PSU cooperative center on reproduction experience. Contemp Clin Trials (2007) 0.85
Troglitazone decreases adrenal androgen levels in women with polycystic ovary syndrome. Fertil Steril (2003) 0.84
Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. Hum Reprod (2011) 0.84
Cholesterol side-chain cleavage gene expression in theca cells: augmented transcriptional regulation and mRNA stability in polycystic ovary syndrome. PLoS One (2012) 0.83
Letrozole or clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med (2014) 0.83
A variant in the fibrillin-3 gene is associated with TGF-β and inhibin B levels in women with polycystic ovary syndrome. Fertil Steril (2010) 0.83
Metabolic and cardiovascular genes in polycystic ovary syndrome: a candidate-wide association study (CWAS). Steroids (2011) 0.83
Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug? J Clin Endocrinol Metab (2008) 0.83
Brachial artery conductance during reactive hyperemia is increased in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol (2010) 0.83
PDE8A genetic variation, polycystic ovary syndrome and androgen levels in women. Mol Hum Reprod (2009) 0.83
Emerging concepts about prenatal genesis, aberrant metabolism and treatment paradigms in polycystic ovary syndrome. Endocrine (2012) 0.82
Polymorphisms in the SHBG gene influence serum SHBG levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab (2011) 0.82
Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial. Obstet Gynecol (2012) 0.81
Longterm management of Polycystic Ovarian Syndrome (PCOS). Mol Cell Endocrinol (2012) 0.81
Proactively establishing a biologic specimens repository for large clinical trials: an idea whose time has come. Syst Biol Reprod Med (2011) 0.81
Metformin as adjuvant therapy to IVF in women with PCOS: when is intention-to-treat unintentional? Hum Reprod (2011) 0.81
Extended-release metformin does not reduce the clomiphene citrate dose required to induce ovulation in polycystic ovary syndrome. J Clin Endocrinol Metab (2008) 0.81
Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study. Fertil Steril (2011) 0.80
Birth experience in women with low, intermediate or high levels of fear: findings from the first baby study. Birth (2013) 0.80
Acupuncture and clomiphene citrate for live birth in polycystic ovary syndrome: study design of a randomized controlled trial. Evid Based Complement Alternat Med (2013) 0.80
Steroidogenic regulatory factor FOS is underexpressed in polycystic ovary syndrome (PCOS) adipose tissue and genetically associated with PCOS susceptibility. J Clin Endocrinol Metab (2012) 0.80
Body mass index and intercourse compliance. Fertil Steril (2009) 0.80
Reproductive impact of polycystic ovary syndrome. Curr Opin Endocrinol Diabetes Obes (2012) 0.80
Does polycystic ovary syndrome increase the disparity in metabolic syndrome and cardiovascular-related health for African-American women? Semin Reprod Med (2008) 0.80
Erectile dysfunction: does insulin resistance play a part? Fertil Steril (2007) 0.80
Intercourse compliance, ovulation, and treatment success in the National Institute of Child Health and Human Development-Reproductive Medicine Network's Pregnancy in Polycystic Ovary Syndrome (PPCOS) Trial. Fertil Steril (2009) 0.80